Webinar Leaders

House Speaker

Alexandra Watt,
Research Analyst – Gene Therapy
Beacon Targeted Therapies

Manuela Corti, PhD

Guest Speaker

Manuela Corti, PhD
Assistant Professor, Department of Pediatrics, University of Florida

Mark Milton, PhD

Guest Speaker

Mark Milton, PhD 
Global Head, Pharmacokinetic Sciences Ophthalmology Therapeutic Area & Department Lead for Gene Therapies, Novartis

Barry J. Byrne, M.D, PhD

Guest Speaker

Barry J. Byrne, M.D, PhD
Associate Chair of Pediatrics and Director of the Powell Gene Therapy Center, University of Florida

Speak with our team about Beacon Gene Therapy

What is Beacon Gene Therapy?


Beacon Gene Therapy is a manually curated database solution that includes clinical trial and drug records for preclinical, active, approved, and discontinued:

  • Non-viral and viral vector delivered gene therapies (in vivo and ex vivo)
  • Antisense or other naked DNA technologies (shRNA, siRNA, mRNA, etc.)
  • Empty Vector Trials
  • Other comparable modalities within gene therapy whether cell-free or cell-based
  • Will not cover CAR-T or Non-CAR-T oncology therapies (This is covered in Beacon Adoptive Cell)
  • Beacon Gene Therapy covers all genetically driven non-oncology indications that utilize gene therapy to mediate the condition.

Find out More

Our Gene Therapy Team



Alexandra Watt

Alexandra Watt – Research Analyst

Paulina Szymanska

Paulina Szymanska – Senior Account Manager

Contact Us

What is Beacon?

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more